Correlation Between Pfizer and Exchange Listed

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Exchange Listed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Exchange Listed into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Exchange Listed Funds, you can compare the effects of market volatilities on Pfizer and Exchange Listed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Exchange Listed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Exchange Listed.

Diversification Opportunities for Pfizer and Exchange Listed

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pfizer and Exchange is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Exchange Listed Funds in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exchange Listed Funds and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Exchange Listed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exchange Listed Funds has no effect on the direction of Pfizer i.e., Pfizer and Exchange Listed go up and down completely randomly.

Pair Corralation between Pfizer and Exchange Listed

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Exchange Listed. In addition to that, Pfizer is 1.31 times more volatile than Exchange Listed Funds. It trades about -0.04 of its total potential returns per unit of risk. Exchange Listed Funds is currently generating about 0.12 per unit of volatility. If you would invest  2,781  in Exchange Listed Funds on September 1, 2024 and sell it today you would earn a total of  472.00  from holding Exchange Listed Funds or generate 16.97% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.21%
ValuesDaily Returns

Pfizer Inc  vs.  Exchange Listed Funds

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Exchange Listed Funds 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Exchange Listed Funds are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent basic indicators, Exchange Listed may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pfizer and Exchange Listed Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Exchange Listed

The main advantage of trading using opposite Pfizer and Exchange Listed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Exchange Listed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exchange Listed will offset losses from the drop in Exchange Listed's long position.
The idea behind Pfizer Inc and Exchange Listed Funds pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
CEOs Directory
Screen CEOs from public companies around the world
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world